![](https://www.pdfsearch.io/img/f26ef2380ba125c0f06e87eca386a73b.jpg) Date: 2016-10-09 05:13:10
| | Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1 Add to Reading ListSource URL: publications.oncomed.comDownload Document from Source Website File Size: 321,05 KBShare Document on Facebook
|